Physician profile
Benjamin Berenfeld
NPI 1548431687
$14,514.05
in general payments reported to CMS, 2019-2025
9 companies · $30.74 in 2025
The $30.74 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,962 · 2020: $309 · 2021: $2,716 · 2022: $185 · 2023: $8,645 · 2024: $667 · 2025: $30.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,550 · Travel and Lodging: $558 · Food and Beverage: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,550.00 |
| Travel and Lodging | $557.86 |
| Food and Beverage | $234.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $8,550.00 | 2023 | Na, Lcp |
| Depuy Synthes Sales INC. | $2,715.58 | 2021 | |
| Arthrex, INC. | $2,130.47 | 2019-2024 | |
| Gotham Surgical Solutions & Devices, INC. | $808.08 | 2019-2024 | |
| Trimed, INC. | $184.66 | 2022 | |
| Acumed LLC | $34.04 | 2023 | Acumed |
| Stryker Corporation | $33.72 | 2023 | Variax, Axsos |
| Zimmer Biomet Holdings, INC. | $30.74 | 2025 | Saw Guide |
| Integra Lifesciences Corporation | $26.76 | 2023 | Tenoglide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Berenfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.